Format

Send to

Choose Destination
See comment in PubMed Commons below
Emerg Infect Dis. 2014 Feb;20(2):201-10. doi: 10.3201/eid2002.131220.

Seven-valent pneumococcal conjugate vaccine and nasopharyngeal microbiota in healthy children.

Abstract

Seven-valent pneumococcal conjugate vaccine (PCV-7) is effective against vaccine serotype disease and carriage. Nevertheless, shifts in colonization and disease toward nonvaccine serotypes and other potential pathogens have been described. To understand the extent of these shifts, we analyzed nasopharyngeal microbial profiles of 97 PCV-7-vaccinated infants and 103 control infants participating in a randomized controlled trial in the Netherlands. PCV-7 immunization resulted in a temporary shift in microbial community composition and increased bacterial diversity. Immunization also resulted in decreased presence of the pneumococcal vaccine serotype and an increase in the relative abundance and presence of nonpneumococcal streptococci and anaerobic bacteria. Furthermore, the abundance of Haemophilus and Staphylococcus bacteria in vaccinees was increased over that in controls. This study illustrates the much broader effect of vaccination with PCV-7 on the microbial community than currently assumed, and highlights the need for careful monitoring when implementing vaccines directed against common colonizers.

TRIAL REGISTRATION:

ClinicalTrials.gov NCT00189020.

KEYWORDS:

PCV-7; bacteria; children; colonization; nasopharyngeal microbiota; pneumococcal conjugate vaccination; pneumococcal conjugate vaccine; pneumococci; randomized controlled trial; respiratory tract; seven-valent pneumococcal conjugate vaccine

PMID:
24447437
PMCID:
PMC3901477
DOI:
10.3201/eid2002.131220
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for CDC-NCEZID Icon for PubMed Central
    Loading ...
    Support Center